about
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionThe soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entryGalectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entrycis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptorDC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in transModes of paramyxovirus fusion: a Henipavirus perspectiveMicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiationTwo key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virusConstraints on the Genetic and Antigenic Variability of Measles VirusISG15 deficiency and increased viral resistance in humans but not miceA broad-spectrum antiviral targeting entry of enveloped virusesInterferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterolCRISPR/Cas9 allows efficient and complete knock-in of a destabilization domain-tagged essential protein in a human cell line, allowing rapid knockdown of protein functionCrystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers AssemblyCCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domainsNipah virus matrix protein: expert hacker of cellular machines.Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.Efficient construction of an inverted minimal H1 promoter driven siRNA expression cassette: facilitation of promoter and siRNA sequence exchange.Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsEndothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation.A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virusCD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cellsHuman milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN).Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors.Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: Consequences for HIV infection and immunity.EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus.Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.Evidence for henipavirus spillover into human populations in Africa.Taxonomy of the order Mononegavirales: update 2017.Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4.Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptorsAn altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.
P50
Q21089597-97D39094-E5CC-4D77-A3DD-5FDBB74B3879Q24299966-C3184ED0-51B4-4401-B19E-BF86021405DDQ24306482-184687D0-CEF8-4BCB-856C-66C6310B5B2AQ24530658-9D58B9FC-89CD-4D57-AF09-28AA64CC8C32Q24601035-F4CA1151-5B3E-4882-A144-77D70A40C177Q24604089-758C1930-45E5-4E88-94BA-22FC601134EAQ24628741-66B9ABF4-8FDC-4762-8988-0D0A587C7EF2Q25257200-9F77F7B7-957E-4C5C-93EF-382740F614DCQ26750558-3FE58B21-6CB8-418D-BF0C-D5C434A6876EQ27317417-A612DCF2-384C-4AA2-974D-956ADB0156FCQ27491286-EC5F8ABA-CF6E-4A17-9F7F-4B8AC6508CB4Q28282311-FDA3406E-0A61-457E-8D63-194B3E251C1BQ28538004-EA935D15-8778-4134-B6C3-9CFF96D1B294Q28551413-210A069A-5578-41FE-A1F0-B61B9A26CBC6Q28646662-9DBC8AFB-6345-4D9D-8A97-0335DC225BC2Q30249294-EF077E3C-5E3C-4D16-9077-1F79ACEA722BQ30368610-F3CA1EA4-D211-4D7A-B002-43631D4BE76BQ33294830-7841B0A2-46DA-4EB5-ABB4-5E8F62B7B087Q33429049-C4072304-0B65-40D7-B0A3-2B3A1B3EB508Q33640112-3D880F2A-F625-4362-8A04-2625F91D34FAQ33697336-5CDFA7F1-E6FE-42E3-8CB8-6B208E7FB49EQ33750025-560B3369-A27B-4524-A645-3E7B426B7649Q33754936-18956445-B1FA-486C-AF43-6AB7FEDA11DFQ33840771-20F709FE-AC04-4EA3-BFCD-73B135D77AB6Q33848876-45D78A96-5D78-4C2D-9C11-BEBCA488E3CCQ33857491-BF6AA48B-4529-49BB-95E0-2B2A15F8DFEDQ33922895-E66A17AC-4F01-4291-BB0C-47758BF99A54Q33990552-218E66D8-9928-40CD-80BC-BC33133FC110Q34016229-55E2D62A-0388-406B-85BB-14B492967E48Q34039661-3734D747-9DF6-4DBA-8D2B-72C88FA49BBBQ34142247-82608182-1BED-4705-9A09-365D9CC8E24AQ34432746-D6831134-94F8-47E9-98E8-A6D193EA1665Q34503200-C8B3595F-5778-47F8-B819-5499646855C7Q34541512-868EE602-2603-4B57-A043-075B8D9E24C7Q34554971-6CF59A78-7F17-4147-9409-C037418098F9Q34610959-452CB8C0-BB4B-4E98-B536-12AC6D8E7F15Q34792976-F284E8ED-B915-4598-B584-FD184680067EQ34978997-9902FB83-3E83-405E-80F6-0F192360FE17Q34987062-DE26F864-547A-4D27-8775-6C0CC2074F69Q35076790-52D81900-F416-4F2E-A3EB-9CA904860450
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Benhur Lee
@ast
Benhur Lee
@en
Benhur Lee
@es
Benhur Lee
@nl
Benhur Lee
@sl
type
label
Benhur Lee
@ast
Benhur Lee
@en
Benhur Lee
@es
Benhur Lee
@nl
Benhur Lee
@sl
prefLabel
Benhur Lee
@ast
Benhur Lee
@en
Benhur Lee
@es
Benhur Lee
@nl
Benhur Lee
@sl
P1053
A-8554-2016
D-4434-2012
P106
P1153
8128481100
P31
P3829
P496
0000-0003-0760-1709
P569
2000-01-01T00:00:00Z